Abu Dhabi: Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, has chaired a meeting of the Emirates Genome Council and approved the 2026-2031 National Genomics Masterplan.
The masterplan sets out the next phase of clinical initiatives and applications under the UAE’s National Genome Strategy, which shifts the focus from genomic data collection to implementation in advanced health, early prevention and precise, personalised medicine.
Get updated faster and for FREE: Download the Gulf News app now - simply click here.
During the meeting, taking place as part of the UAE Government Annual Meetings, Sheikh Khaled reviewed the latest updates and achievements of the Emirati Genome Program, which has reached its milestone of one million participants, underscoring its standing as the world’s most comprehensive population genome programme.
Sheikh Khaled emphasised the importance of expanding preventative care programmes and accelerating the adoption of genomic research and innovation. He highlighted the need to translate research findings into practical applications that further enhance community health and quality of life, cementing the UAE’s leadership in genomics and precision medicine.
He also reviewed preparations to launch the world’s largest initiative of its kind in providing personalised genomic reports to 900,000 participants of the Emirati Genome Program.
